Celldex Therapeutics Inc (NASDAQ:CLDX)

27.17
Delayed Data
As of Mar 27
 +1.21 / +4.66%
Today’s Change
10.76
Today|||52-Week Range
32.82
+48.88%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 36.00, with a high estimate of 45.00 and a low estimate of 32.00. The median estimate represents a +32.50% increase from the last price of 27.17.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$662.5K
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.04%
 
 
 
 
 
 
Growthannually -17.80%
 
 
 
 
 
 

Sales

Growthquarterly -55.15%
 
 
 
 
 
 
Growthannually 1.38%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account